Considerations in Contamination Control

A contamination control strategy can prevent contamination in sterile product manufacturing. The right system, equipment, and personnel training are also essential to mitigate risk.

Pharmaceutical Technology spoke with Richard Denk, senior consultant aseptic processing and containment, SKAN AG, about the risks of contamination in biopharmaceutical manufacturing and how this risk can be mitigated.

Read this article in Pharmaceutical Technology Biologics and Sterile Drug Manufacturing May 2020 eBook.

Article Details

Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2020
May 2020
Pages: 38–42

Citation

When referring to this article, please cite it as S. Haigney, “Considerations in Contamination Control," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).

Articles in this issue

over 5 years ago

Article

On Point: Biologics Drive Growth in Pre-Filled Syringes

over 5 years ago

Article

Instrumenting Single-Use Processes

over 5 years ago

Article

Best systems and equipment for contamination control

over 5 years ago

Article

Building Data Quality In Generates Quality Data Out

over 5 years ago

Article

Detecting Contamination in Cell Therapies

over 5 years ago

Article

Optimizing Viral Vector Manufacturing for Gene Therapy

over 5 years ago

Article

Minimizing Contamination During Biopharma R&D

over 5 years ago

Article

Complications in Process Simulation Execution

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!